Skip to main content
WELLBIOTEC CO.,LTD logo

WELLBIOTEC CO.,LTD — Investor Relations & Filings

Ticker · 010600 ISIN · KR7010600005 KO Manufacturing
Filings indexed 423 across all filing types
Latest filing 2025-05-20 Legal Proceedings Report
Country KR South Korea
Listing KO 010600

About WELLBIOTEC CO.,LTD

http://www.wellbiotec.com/?language=eng

WELLBIOTEC CO.,LTD. is a diversified company with operations in several sectors. Its business activities include the development and distribution of biopharmaceutical products, such as specialized medicines, health functional foods, and diagnostic kits. The company is also involved in the electric vehicle (EV) charging business and logistics. Additionally, it manufactures and sells leather products for fashion goods, including shoes and handbags.

Recent filings

Filing Released Lang Actions
기타경영사항(자율공시) (상장폐지결정 효력정지 가처분 신청)
Legal Proceedings Report Classification · 100% confidence The document is a formal disclosure regarding a legal action (an injunction application) filed by Wellbiotech against the Korea Exchange to suspend the effect of a delisting decision. Since this document pertains to a significant legal proceeding and regulatory dispute, it falls under the 'Legal Proceedings Report' category.
2025-05-20 Korean
기타시장안내 (상장·공시위원회 결과)
Delisting Announcement Classification · 100% confidence The document is an official announcement from the Korea Exchange regarding the delisting of Wellbiotech due to audit opinion disclaimers. Since it explicitly announces the decision to remove the company's stock from the exchange, it falls under the Delisting Announcement category.
2025-05-19 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for Wellbiotec Co., Ltd. covering the period from January 1, 2025, to March 31, 2025. It contains detailed corporate information, business descriptions, financial data, and management disclosures, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2025
2025-05-15 Korean
기타시장안내 (개선계획 이행여부 심의요청서 접수)
Delisting Announcement Classification · 100% confidence The document is an official notice from the Korea Exchange (KRX) regarding 'Wellbiotech'. It details the submission of an improvement plan implementation review request following a delisting risk event. This is a regulatory announcement concerning market status, listing eligibility, and trading suspension, which falls under the 'Regulatory Filings' category as it does not fit into specific categories like M&A, dividends, or financial reports.
2025-04-23 Korean
기타시장안내 (개선기간 종료)
Delisting Announcement Classification · 100% confidence The document is an official notice from the Korea Exchange (KRX) regarding the status of Well Biotech's listing, specifically concerning the expiration of an improvement period and the subsequent procedures for delisting review. This is a regulatory announcement regarding market status and listing compliance, which does not fit into specific categories like M&A, dividends, or financial reports. Therefore, it falls under the 'Regulatory Filings' (RNS) category as a general regulatory announcement.
2025-04-14 Korean
기타시장안내 (상장폐지 이의신청서 제출)
Delisting Announcement Classification · 100% confidence The document is an official notice from the Korea Exchange (KRX) regarding Well Biotech's submission of an objection to a delisting decision due to a disclaimer of opinion in the audit report. While it mentions delisting, it is a regulatory announcement regarding the status of the listing process rather than a final delisting notice or a specific corporate action report. Given the nature of the announcement as a regulatory update regarding market status, 'RNS' (Regulatory Filings) is the most appropriate classification.
2025-04-10 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.